The company plans to address the FDA's concerns and resubmit its application for the product, which aims to treat so-called "off episodes", which affects nearly all patients of Parkinson's, heightening symptoms such as tremors and difficulty in walking, as medication wears off.
US FDA declines to approve Supernus' Park... - Cure Parkinson's
US FDA declines to approve Supernus' Parkinson's combination again
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Thanks for sharing! Sounds promising!
FDA Issues Complete Response Letter for Apomorphine Infusion Device SPN-830 in Parkinson Disease Treatment
Not what you're looking for?
You may also like...
Why is Ambroxol not approved by the FDA?
Why is Ambroxol not approved by the FDA when it is readily available in Europe in countries with...
FDA Approves Focused Ultrasound Treatment for Parkinson’s Disease
fusfoundation.org/news/fda-approves-focused-ultrasound-treatment-for-parkinsons-disease...
New Nrf2 activator drug gets FDA approval for Freidrich ataxia
https://practicalneurology.com/news/omaveloxolone-approved-by-fda-as-first-therapy-for-friedreich-at
Overnight the FDA was approving clinical trials for treatments for the Corona virus. Why can’t it work on Parkinson's at the same pace
coronavirus happened, it seemed as if overnight the FDA was approving clinical trials for...
Today we announced that the US FDA has cleared IND applications for 4dpharmaplc’s LiveBiotherapeutics MRx0005 and MRx0029, Phase I
Today we announced that the US FDA has cleared IND applications for @4dpharmaplc’s...